SCHEMBL29566580

SCHEMBL29566580

Cc1cccc(C)c1-c1cc(Oc2ccc(CCN(C)C)c(Cl)c2)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 5/20 0.34
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ NMT1 P30419 1/20 0.33
▸ CCNT1 O60563 1/20 0.33
▸ CCNB2 O95067 1/20 0.33
▸ CCNE2 O96020 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ CCNB1 P14635 1/20 0.33
▸ CCNE1 P24864 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ CCNB3 Q8WWL7 1/20 0.33
▸ GPR119 Q8TDV5 2/20 0.32
▸ SRC P12931 2/20 0.32
▸ BRD4 O60885 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310116 1.00 HTR6 (0.34) HTR6PIK3CDPIK3CBMTORPIK3CG
SCHEMBL29566654 0.88 NMT1 (0.37) HTR6PIK3CDPIK3CBMTORPIK3CG
SCHEMBL24310059 0.88 NMT1 (0.37) HTR6PIK3CDPIK3CBMTORPIK3CG
SCHEMBL24310148 0.85 MKNK1 (0.31) HTR7MKNK1
SCHEMBL26810218 0.84 KMT2A (0.40) GPR119TSHRSMN1; SMN2
SCHEMBL26810235 0.84 CACNA1B (0.34) HTR6PIK3CDPIK3CBMTORPIK3CG
SCHEMBL29566254 0.84 TSHR (0.35) PIK3CDPIK3CBMTORPIK3CGCCNT1
SCHEMBL24310549 0.83 ACLY (0.38) GPR119TSHRSMN1; SMN2
SCHEMBL29566982 0.83 ACLY (0.38) GPR119TSHRSMN1; SMN2
SCHEMBL26856825 0.83 MKNK1 (0.38) HTR6PIK3CDPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback